医用臭氧疼痛触发点注射治疗腰部肌筋膜疼痛综合征临床研究

Clinical observation of medical ozone injection in trigger point on psoas myofascial pain syndrom

目的评价医用臭氧疼痛触发点注射治疗腰部肌筋膜疼痛综合征(Myofascial Pain Syndrom,MPS)的效果与安全性。方法采用前瞻性随机对照的研究方法,将78例患者随机分为两组,臭氧治疗组应用低浓度医用臭氧,常规治疗组应用利多卡因+维生素B6+甲钴胺和地塞米松棕榈酸酯,均行疼痛触发点浸润注射。治疗2周后采用视觉模拟评分(Visual AnalogueScale,VAS)和日本骨科学会下腰痛评估量表(Low Lumbar Pain Scales,LLPS)对照评价两组疗效。结果治疗前后比较,两组VAS评分分别从6.2±1.7降至1.1±0.8和从5.6±1.2降至2.3±1.1(均P<0.05),LLPS明显改善(均P<0.01);两组比较,臭氧组VAS评分降低幅值显著大于对照组(P<0.05),优良率明显高于对照组(89.74%比71.79%,P<0.05);LLPS改善程度明显优于对照组(均P<0.05);不良反应明显少于对照组。结论医用臭氧疼痛触发点注射治疗腰部MPS与常规麻醉剂加激素封闭同样有效,优良率更高,安全性较高,未见明显不良反应。

Objective To evaluate therapeutic effects and safety of medical ozone injection in trigger point on psoas Myofascial Pain Syndrome（MPS）. Methods Totally 78 cases of MPS were randomly divided into control group and observational group. One group were treated with Low Concentration ozone,another group with lidocain,VitB6,mecobalamin,limethason,all were injected in trigger point. The VAS and LLPS scales were evaluated after 2 weeks. Results After 2 weeks,The VAS scales in both groups were respectively decreased from 6.2±1.7 to 1.1±0.8 and from 5.6±1.2 to 2.3±1.1（P0.05）. The LLPS were improved obviously （P0.01）. But VAS value decreased in ozone group was significantly greater than in control group（P0.05）. The kolmert was higher significantly（89.74% vs 71.79%,P0.05）. The LLPS were improved more obviously in ozone group than in control group（all P0.01）. Side effects were fewer significantly. Conclusions Medical ozone injection in trigger point on MPS was a safe and more effective therapeutic method than routine methods.